Moneycontrol PRO
HomeNewsBusinessMarketsLockdown wealth creator: This stock has doubled since March 24, time to book profit?

Lockdown wealth creator: This stock has doubled since March 24, time to book profit?

Someone who is already invested can take some profit off the table because of expensive valuations while for new investors it is a good buy on dips stock.

June 22, 2020 / 14:35 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    When the Indian market made a low on March 24, there was one stock that was preparing for a catapult swing to record highs.

    GMM Pfaudler (GMMP), which is a leading supplier of process equipment to the pharmaceutical and chemical industry, doubled investors’ wealth in just three months.

    The stock which closed at Rs 2,100 on March 24 when the Nifty50 made a swing low of Rs 7,511, rose over 120 percent to hit a record high of Rs 4,700 as on June 10.

    On June 19, the stock closed at Rs 4,205 on the BSE - a 100 percent gain from March low.

    GMM Pfaudler has a market share of more than 50 percent in Glass Lined equipment. It is the market leader in India. Over the years, GMM Pfaudler has diversified its product portfolio to include Mixing Systems, Filtration & Drying Equipment, Engineered Systems, and Tailor Made Process Equipment.

    COVID-19 Vaccine

    Frequently Asked Questions

    View more
    How does a vaccine work?

    A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

    How many types of vaccines are there?

    There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

    What does it take to develop a vaccine of this kind?

    Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

    View more
    Show

    Experts are of the view that the stock is poised to display strong growth in the upcoming quarters, as it might turn out to be a key beneficiary of the shift of manufacturing of Chemical & API business from China to India.

    March quarter results got impacted by lockdown but should bounce back or normalise in the second half of the financial year, suggest experts. However, a recent rally in the stock makes analyst cautious in the short term, but the long-term potential still remains intact.

    “We believe that GMM Pfaudler is uniquely positioned as it is the market leader in the glass-lined equipment business and caters to the fast-growing segment of chemicals and pharmaceuticals. The company is seeing strong order inflow from the user industries driven by the shift of manufacturing of Chemical & API business from China to India,” Jyoti Roy, DVP Equity Strategist, Angel Broking Ltd told Moneycontrol.

    “While the company reported a below-expected set of numbers for Q4 FY20 due to lockdown, we expect operations to normalise by end of Q2 FY21 given strong demand by end-user industry. Despite the COVID-19 crisis, we expect the company to post strong revenue and earnings growth of 21.1% and 43.1% respectively between FY20-FY22E,” he said.

    What should investors do?

    GMM Pfaudler share price has more than doubled in the last 3 months. Maximum wealth was generated during the lockdown period. The March quarter results were slightly disappointing due to the lockdown but experts feel that growth will revive in the coming quarters.

    Someone who is already invested can take some profits off the table because of expensive valuations while for new investors it is a good buy on dips stock. It is a leading supplier of process equipment to the pharmaceutical and chemical industry segments.

    “While we feel that the company has strong growth prospects over the next few years, at Rs 4,297, the stock is trading at a relatively expensive valuation of 43.1xFY21 EPS estimates of Rs 99.8 which factors in the strong growth potential,” said Roy of Angel Broking Ltd.

    He further added that given expensive valuations relative to historical average we believe that upsides would be capped from current levels and therefore existing investors can look at exiting the stock partially at current levels.

    Technical Recommendations:

    Technical experts feel that investors could look at booking partial profits, while a re-entry could be seen on dips.

    This counter appears to have slipped in a consolidation mode between Rs 4,620–4,176 levels, after appreciating investors’ wealth by more than 100 percent from the panic lows of March placed at Rs 1,817.

    “The volumes are very low on this counter which can result in sharp moves in both the directions. Hence, any breakdown below 4,176 can be sharp and can drag down this counter in the zone of 3,700 – 3,500,” Mazhar Mohammad, Chief Strategist – Technical Research & Trading Advisory, Chartviewindia.in told Moneycontrol.

    “Considering the recent rally and the current sideways phase, it looks prudent on the part of traders to book profits at current levels and consider re-entry either on correction towards 3,550 levels or on a fresh breakout above 4,620 for a target of 4,950,” he said.

    Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Kshitij Anand
    Kshitij Anand is the Editor Markets at Moneycontrol.
    first published: Jun 22, 2020 02:23 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347